FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387206470> ?p ?o ?g. }

• W4387206470 endingPage "e146" @default.
• W4387206470 startingPage "e145" @default.
• W4387206470 abstract "Recent advances to preserve neurocognitive function in patients treated for brain metastases include stereotactic radiosurgery (SRS), hippocampal avoidance whole brain radiation therapy (HA-WBRT), and memantine administration. However, 23% of patients receiving HA-WBRT and memantine on NRG-CC001 still experienced executive function deterioration at 4 months, with 12% experiencing total recall and delayed recognition deterioration at 6 months. The hippocampus, corpus callosum, fornix, and amygdala are key neurocognitive substructures with a low propensity for brain metastases. Herein, we report our preliminary experience using an advanced memory-avoidance WBRT (MA-WBRT) approach sparing these substructures for patients with multiple (>15) brain metastases.Ten consecutive patients treated with MA-WBRT on a phase 2 clinical trial (OSU-21074) were reviewed. In each patient, the hippocampi, amygdalae, corpus callosa, and fornix were contoured. Patients were not eligible for MA-WBRT if they had metastases in these substructures. A memory- avoidance region created using a 5mm volumetric expansion around these substructures. Hotspots were avoided in the hypothalamus and pituitary gland. Dose constraints for these avoidance structures were modeled after NRG CC-001 and include a D100% ≤ 9 Gy and a D0.03 cc ≤ 16 (acceptable to 20 Gy). Coverage of brain metastases was prioritized over memory avoidance dose constraints. Linac-based volumetric modulated arc therapy (VMAT) plans were generated for a prescription dose of 30 Gy in 10 fractions.On average, the memory avoidance structure volume was 37.1 ccs (Range: 25.2-44.6 ccs), occupying 2.5% of the entire whole brain target volume. All treatment plans met the D100% dose constraint, and 8/10 plans met the D0.03cc constraint, with priority given to tumor coverage for the remaining 2 cases. VMAT spared the memory avoidance structures with a median dose range of 10.8-14.2 Gy and a maximum dose (D0.03cc) range of 15.6-22.7 Gy. The mean dose to the memory avoidance structures was 12.7 Gy (Range: 11.5-13.8 Gy). Target coverage (D98% > 25 Gy) and homogeneity (D2% ≤ 37.5 Gy) were achieved for all plans.Modern VMAT techniques allow for sparing of the hippocampus, amygdala, corpus callosum, and fornix with good target coverage and homogeneity. Prospective quality of life and cognitive data including are being collected and include the Functional Assessment of Cancer Therapy - Brain (Fact-Br), Hopkins Verbal Learning Test (HLVT-R), Trail Making Test A/B (TMT-A/B) and Controlled Oral Word Association Test (COWAT). After enrollment is completed, these data will be evaluated to assess the efficacy of MA-WBRT to mitigate declines in quality of life and cognition after whole brain radiation." @default.
• W4387206470 created "2023-09-30" @default.
• W4387206470 creator A5001340260 @default.
• W4387206470 creator A5016378224 @default.
• W4387206470 creator A5017206877 @default.
• W4387206470 creator A5019250849 @default.
• W4387206470 creator A5022829822 @default.
• W4387206470 creator A5023083148 @default.
• W4387206470 creator A5025879011 @default.
• W4387206470 creator A5027809188 @default.
• W4387206470 creator A5036139080 @default.
• W4387206470 creator A5037392091 @default.
• W4387206470 creator A5050218301 @default.
• W4387206470 creator A5059128200 @default.
• W4387206470 creator A5066127518 @default.
• W4387206470 creator A5067706276 @default.
• W4387206470 creator A5068961161 @default.
• W4387206470 creator A5073117866 @default.
• W4387206470 creator A5074650908 @default.
• W4387206470 date "2023-10-01" @default.
• W4387206470 modified "2023-10-17" @default.
• W4387206470 title "Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy" @default.
• W4387206470 doi "https://doi.org/10.1016/j.ijrobp.2023.06.960" @default.
• W4387206470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784722" @default.
• W4387206470 hasPublicationYear "2023" @default.
• W4387206470 type Work @default.
• W4387206470 citedByCount "0" @default.
• W4387206470 crossrefType "journal-article" @default.
• W4387206470 hasAuthorship W4387206470A5001340260 @default.
• W4387206470 hasAuthorship W4387206470A5016378224 @default.
• W4387206470 hasAuthorship W4387206470A5017206877 @default.
• W4387206470 hasAuthorship W4387206470A5019250849 @default.
• W4387206470 hasAuthorship W4387206470A5022829822 @default.
• W4387206470 hasAuthorship W4387206470A5023083148 @default.
• W4387206470 hasAuthorship W4387206470A5025879011 @default.
• W4387206470 hasAuthorship W4387206470A5027809188 @default.
• W4387206470 hasAuthorship W4387206470A5036139080 @default.
• W4387206470 hasAuthorship W4387206470A5037392091 @default.
• W4387206470 hasAuthorship W4387206470A5050218301 @default.
• W4387206470 hasAuthorship W4387206470A5059128200 @default.
• W4387206470 hasAuthorship W4387206470A5066127518 @default.
• W4387206470 hasAuthorship W4387206470A5067706276 @default.
• W4387206470 hasAuthorship W4387206470A5068961161 @default.
• W4387206470 hasAuthorship W4387206470A5073117866 @default.
• W4387206470 hasAuthorship W4387206470A5074650908 @default.
• W4387206470 hasConcept C118552586 @default.
• W4387206470 hasConcept C121608353 @default.
• W4387206470 hasConcept C126322002 @default.
• W4387206470 hasConcept C126838900 @default.
• W4387206470 hasConcept C169900460 @default.
• W4387206470 hasConcept C172467417 @default.
• W4387206470 hasConcept C2778164965 @default.
• W4387206470 hasConcept C2778677889 @default.
• W4387206470 hasConcept C2779013556 @default.
• W4387206470 hasConcept C2779911601 @default.
• W4387206470 hasConcept C2780387249 @default.
• W4387206470 hasConcept C2781161787 @default.
• W4387206470 hasConcept C509974204 @default.
• W4387206470 hasConcept C71924100 @default.
• W4387206470 hasConceptScore W4387206470C118552586 @default.
• W4387206470 hasConceptScore W4387206470C121608353 @default.
• W4387206470 hasConceptScore W4387206470C126322002 @default.
• W4387206470 hasConceptScore W4387206470C126838900 @default.
• W4387206470 hasConceptScore W4387206470C169900460 @default.
• W4387206470 hasConceptScore W4387206470C172467417 @default.
• W4387206470 hasConceptScore W4387206470C2778164965 @default.
• W4387206470 hasConceptScore W4387206470C2778677889 @default.
• W4387206470 hasConceptScore W4387206470C2779013556 @default.
• W4387206470 hasConceptScore W4387206470C2779911601 @default.
• W4387206470 hasConceptScore W4387206470C2780387249 @default.
• W4387206470 hasConceptScore W4387206470C2781161787 @default.
• W4387206470 hasConceptScore W4387206470C509974204 @default.
• W4387206470 hasConceptScore W4387206470C71924100 @default.
• W4387206470 hasIssue "2" @default.
• W4387206470 hasLocation W43872064701 @default.
• W4387206470 hasLocation W43872064702 @default.
• W4387206470 hasOpenAccess W4387206470 @default.
• W4387206470 hasPrimaryLocation W43872064701 @default.
• W4387206470 hasRelatedWork W151365997 @default.
• W4387206470 hasRelatedWork W2067567440 @default.
• W4387206470 hasRelatedWork W2080299590 @default.
• W4387206470 hasRelatedWork W2141673430 @default.
• W4387206470 hasRelatedWork W2161199552 @default.
• W4387206470 hasRelatedWork W2173551132 @default.
• W4387206470 hasRelatedWork W2388910868 @default.
• W4387206470 hasRelatedWork W2529743430 @default.
• W4387206470 hasRelatedWork W3030041872 @default.
• W4387206470 hasRelatedWork W4362599979 @default.
• W4387206470 hasVolume "117" @default.
• W4387206470 isParatext "false" @default.
• W4387206470 isRetracted "false" @default.
• W4387206470 workType "article" @default.